Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

Cytochrome P450 2C9 gene polymorphism in phenytoin induced gingival enlargement: A case report.

Babu SP, Ramesh V, Samidorai A, Charles NS.

J Pharm Bioallied Sci. 2013 Jul;5(3):237-9. doi: 10.4103/0975-7406.116828.

PMID:
24082701
[PubMed]
Free PMC Article
2.

CYP2C polymorphisms, phenytoin metabolism and gingival overgrowth in epileptic subjects.

Soga Y, Nishimura F, Ohtsuka Y, Araki H, Iwamoto Y, Naruishi H, Shiomi N, Kobayashi Y, Takashiba S, Shimizu K, Gomita Y, Oka E.

Life Sci. 2004 Jan 2;74(7):827-34.

PMID:
14659971
[PubMed - indexed for MEDLINE]
3.

The role of pharmacogenetics in the metabolism of antiepileptic drugs: pharmacokinetic and therapeutic implications.

Klotz U.

Clin Pharmacokinet. 2007;46(4):271-9. Review.

PMID:
17375979
[PubMed - indexed for MEDLINE]
4.

Effect of genetic polymorphisms in cytochrome p450 (CYP) 2C9 and CYP2C8 on the pharmacokinetics of oral antidiabetic drugs: clinical relevance.

Kirchheiner J, Roots I, Goldammer M, Rosenkranz B, Brockmöller J.

Clin Pharmacokinet. 2005;44(12):1209-25. Review.

PMID:
16372821
[PubMed - indexed for MEDLINE]
5.

Polymorphism of human cytochrome P450 enzymes and its clinical impact.

Zhou SF, Liu JP, Chowbay B.

Drug Metab Rev. 2009;41(2):89-295. doi: 10.1080/03602530902843483. Review.

PMID:
19514967
[PubMed - indexed for MEDLINE]
6.

Identification of a null allele of CYP2C9 in an African-American exhibiting toxicity to phenytoin.

Kidd RS, Curry TB, Gallagher S, Edeki T, Blaisdell J, Goldstein JA.

Pharmacogenetics. 2001 Dec;11(9):803-8.

PMID:
11740344
[PubMed - indexed for MEDLINE]
7.

The effect of genetic polymorphism of cytochrome P450 CYP2C9 on phenytoin dose requirement.

van der Weide J, Steijns LS, van Weelden MJ, de Haan K.

Pharmacogenetics. 2001 Jun;11(4):287-91.

PMID:
11434505
[PubMed - indexed for MEDLINE]
8.

Genetic polymorphism of the human cytochrome P450 2C9 gene and its clinical significance.

Wang B, Wang J, Huang SQ, Su HH, Zhou SF.

Curr Drug Metab. 2009 Sep;10(7):781-834. Review.

PMID:
19925388
[PubMed - indexed for MEDLINE]
9.

Association of galactose single-point test levels and phenytoin metabolic polymorphisms with gingival hyperplasia in patients receiving long-term phenytoin therapy.

Lin CJ, Yen MF, Hu OY, Lin MS, Hsiong CH, Hung CC, Liou HH.

Pharmacotherapy. 2008 Jan;28(1):35-41.

PMID:
18154472
[PubMed - indexed for MEDLINE]
10.

Genetic polymorphism of cytochrome P450 2C9 in diphenylhydantoin-induced cutaneous adverse drug reactions.

Lee AY, Kim MJ, Chey WY, Choi J, Kim BG.

Eur J Clin Pharmacol. 2004 May;60(3):155-9. Epub 2004 Mar 16.

PMID:
15024534
[PubMed - indexed for MEDLINE]
11.

CYP2C9*1B promoter polymorphisms, in linkage with CYP2C19*2, affect phenytoin autoinduction of clearance and maintenance dose.

Chaudhry AS, Urban TJ, Lamba JK, Birnbaum AK, Remmel RP, Subramanian M, Strom S, You JH, Kasperaviciute D, Catarino CB, Radtke RA, Sisodiya SM, Goldstein DB, Schuetz EG.

J Pharmacol Exp Ther. 2010 Feb;332(2):599-611. doi: 10.1124/jpet.109.161026. Epub 2009 Oct 23.

PMID:
19855097
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

[Development of rapid genotyping methods for single nucleotide polymorphisms of cytochrome P450 2C9 (CYP2C9) and cytochrome P450 2C19 (CYP2C19) and their clinical application in pediatric patients with epilepsy].

Yamamoto Y, Takahashi Y, Nishimura S, Ikumi Y, Mishima N, Kagawa Y.

Yakugaku Zasshi. 2011;131(5):809-15. Japanese.

PMID:
21532277
[PubMed - indexed for MEDLINE]
Free Article
13.

Association between the CYP2C9 polymorphism and the drug metabolism phenotype.

Topić E, Stefanović M, Samardzija M.

Clin Chem Lab Med. 2004 Jan;42(1):72-8.

PMID:
15061384
[PubMed - indexed for MEDLINE]
14.

Pharmacogenetics of warfarin elimination and its clinical implications.

Takahashi H, Echizen H.

Clin Pharmacokinet. 2001;40(8):587-603. Review.

PMID:
11523725
[PubMed - indexed for MEDLINE]
15.

The effects of genetic polymorphisms of CYP2C9 and CYP2C19 on phenytoin metabolism in Japanese adult patients with epilepsy: studies in stereoselective hydroxylation and population pharmacokinetics.

Mamiya K, Ieiri I, Shimamoto J, Yukawa E, Imai J, Ninomiya H, Yamada H, Otsubo K, Higuchi S, Tashiro N.

Epilepsia. 1998 Dec;39(12):1317-23.

PMID:
9860067
[PubMed - indexed for MEDLINE]
16.

Phenytoin, folic acid and gingival enlargement: Breaking myths.

Nayyar AS, Khan M, Vijayalakshmi KR, Suman B, Subhas GT, Nataraju B, Anitha M.

Contemp Clin Dent. 2014 Jan;5(1):59-66. doi: 10.4103/0976-237X.128666.

PMID:
24808697
[PubMed]
Free PMC Article
17.

Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I.

Zhou SF.

Clin Pharmacokinet. 2009;48(11):689-723. doi: 10.2165/11318030-000000000-00000. Review.

PMID:
19817501
[PubMed - indexed for MEDLINE]
18.

Effect of CYP2C9 genetic polymorphism on the metabolism of flurbiprofen in vitro.

Wang L, Bao SH, Pan PP, Xia MM, Chen MC, Liang BQ, Dai DP, Cai JP, Hu GX.

Drug Dev Ind Pharm. 2014 Aug 21:1-5. [Epub ahead of print]

PMID:
25144335
[PubMed - as supplied by publisher]
19.

CYP2C9, CYP2C19, ABCB1 (MDR1) genetic polymorphisms and phenytoin metabolism in a Black Beninese population.

Allabi AC, Gala JL, Horsmans Y.

Pharmacogenet Genomics. 2005 Nov;15(11):779-86.

PMID:
16220110
[PubMed - indexed for MEDLINE]
20.

The frequency and effects of cytochrome P450 (CYP) 2C9 polymorphisms in patients receiving warfarin.

Tabrizi AR, Zehnbauer BA, Borecki IB, McGrath SD, Buchman TG, Freeman BD.

J Am Coll Surg. 2002 Mar;194(3):267-73.

PMID:
11893129
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk